Furthermore, blocking IL-8 signaling using an anti-IL-8 antibody resulted in decreased tumor growth and improved survival in a glioma mouse model treated with a PD-1-blocking antibody compared to PD-1 antibody alone [214]. The gene discussed is CXCL8; the disease is central nervous system cancer.